Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

More News! 30 Sep 2018

Trouble in the Soil Bed: Sex Toys for Plants

We live in a society obsessed with sex. Yet many of us forget that other living beings can have their own issues and needs in the reproductive area. A group of artists and designers from Slovenia got together to create fictional sex toys for the specific problems of plants. A dildo for carnivorous plants and […]

September 30, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Interview 25 Sep 2018

How to Overcome Failure as a Biotech Company

Turning failure into success is a difficult but much needed skill in a high-risk industry such as biotech. At our latest Labiotech Refresh event, Christine Placet, now the CEO of ophthalmic gene therapy company Horama, shared her personal story of how she saved her previous company, Trophos, from an almost certain failure. The mission of […]

September 25, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Alanna Lynch bioart gut feelings microbiome

News and Trends 22 Sep 2018

Art Made With Kombucha Explores the Science of the Microbiome

Artist Alanna Lynch uses kombucha as an art medium to explore our relationship with the microbiome, which is now in the spotlight of human health. An ancient drink made of fermented tea, kombucha is now, over 2,000 years later, exploding in popularity. This week, Coca-Cola acquired an Australian kombucha company in an aim to enter […]

September 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 19 Sep 2018

This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity Testing

Poietis has partnered with the pharma company Servier to develop a 4D bioprinted liver model that could predict liver toxicity of drugs better than current methods. Liver toxicity testing is one of the key tests that are performed during preclinical trials with investigational drugs. “The role of the liver is to degrade substances toxic to […]

September 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Sep 2018

Update: French Biotech Raises €22M for a Gene Therapy Trial in Retinitis Pigmentosa

Update (18/09/2018): Horama has increased the total raised in its Series B fundraising to €22.5M, with the Belgian fund V-Bio Ventures joining the team of investors backing the company. The funds will be mainly directed at developing Horama’s gene therapy for retinitis pigmentosa. Published on 08/10/2017 Horama has raised a second fundraising round that will support […]

September 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Sep 2018

The First ‘Genomic Internet’ Has Been Launched

The Russian non-profit Zenome.io has launched today the beta release of the first decentralized ‘genomic internet’, which is expected to make possible the safe storage of large amounts of genetic data. Genomics is one of the largest generators of data on the internet, more than Twitter and YouTube according to Zenome. Using a decentralized network […]

September 17, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 16 Sep 2018

Meet the Entrepreneurs Doing Biotech from Shipping Containers in London

Creative biotech startups are brewing inside a shipping container park that offers affordable research space for biologists, engineers and designers working together. The space, called Open Cell, will be opening its doors to the public this week for the London Design Festival. Chip boards made using potato waste, construction materials made with fungi and crystals […]

September 16, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

$bone Therapeutics cell therapy bone fracture$

News and Trends 14 Sep 2018

Cell Therapy Helps Regenerate Difficult Bone Fractures

All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […]

September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Boehringer Ingelheim ViraTherapeutics oncolytic virus

More News! 13 Sep 2018

Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company

Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian biotech company developing oncolytic viral therapies for cancer. ViraTherapeutics develops cancer therapies based on viruses that selectively kill tumor cells, based on the principle that cancer cells show defective mechanisms to defend themselves against viruses that are not able to […]

September 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Sep 2018

Airbus Will Use Recombinant Spider Silk to Build Lightweight Planes

Airbus has signed a partnership with German biotech AMSilk for the development of a new biomaterial to be used in the construction of future high-performance planes. Spider silk is known for having outstanding strength and flexibility. AMSilk uses engineered bacteria to produce spider silk protein, which is then used to create materials with a wide […]

September 12, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Helen Tayton Martin Adaptimmune interview

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in this crowded field, many companies struggle to make therapies that not only are effective and safe, but that can also be scaled-up, manufactured and commercialized. Helen Tayton-Martin, Chief Business Officer at the biotech company Adaptimmune, shares her advice on how […]

September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 10 Sep 2018

10 Biotech Companies in Berlin You Should Know

The vibrant startup scene of the German capital has attracted many biotechs to make it their home. Here are ten biotech companies in Berlin to keep an eye on. Well-known for its history and rich cultural scene, Berlin is also a hotspot for startups of all kinds (including us!). As the headquarters of the successful […]

September 10, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us